| Unique ID issued by UMIN | UMIN000054593 |
|---|---|
| Receipt number | R000062381 |
| Scientific Title | Investigation on complications caused by barium/foaming agents after upper gastrointestinal X-ray examination |
| Date of disclosure of the study information | 2024/07/01 |
| Last modified on | 2024/06/06 16:38:20 |
Investigation on complications caused by barium/foaming agents after upper gastrointestinal X-ray examination
Investigation on complications caused by barium/foaming agents after upper gastrointestinal X-ray examination
Investigation on complications caused by barium/foaming agents after upper gastrointestinal X-ray examination
Investigation on complications caused by barium/foaming agents after upper gastrointestinal X-ray examination
| Japan |
complications caused by barium/foaming agents after upper gastrointestinal X-ray examination
| Hepato-biliary-pancreatic medicine |
Others
NO
In upper gastrointestinal X-ray examinations, a foaming agent is taken immediately before the examination to inflate the stomach with carbon dioxide gas, and the examination is performed using a barium contrast agent. Studies conducted by academic societies and other organizations have revealed the occurrence of accidental symptoms caused by the use of foaming agents and barium contrast agents during examinations, but it is not possible to ascertain the occurrence of accidental symptoms and the severity of symptoms that occur after patients return home. Not yet. This time, we planned a study to investigate the occurrence and severity of symptoms one week after the test.
Safety
Regarding incidental events related to upper gastrointestinal X-ray examination, whether or not they have occurred one week after the examination.
Observational
| 20 | years-old | <= |
| Not applicable |
Male and Female
Those who underwent a complete medical checkup or stomach X-ray examination for gastric cancer screening
Persons who cannot consent to participate in research
5000
| 1st name | TSUNEYA |
| Middle name | |
| Last name | WADA |
Okazaki Medical Association
Harusaki Medical Center
4440875
1-9-1 Tatsumi-nishi Okazaki Aichi
0564521572
t-wada@okazaki-med.or.jp
| 1st name | TSUNEYA |
| Middle name | |
| Last name | WADA |
Okazaki Medical Association
Harusaki Medical Center
4440875
1-9-1 Tatsumi-nishi Okazaki Aichi
0564521572
t-wada@okazaki-med.or.jp
Okazaki Medical Association
Okazaki Medical Association
Non profit foundation
Nagoya City University Hospital
1 Kawasumi Mizuho Nagoya Aichi
052-858-7215
irb_jimu@med.nagoya-cu.ac.jp
NO
| 2024 | Year | 07 | Month | 01 | Day |
Unpublished
Open public recruiting
| 2024 | Year | 01 | Month | 01 | Day |
| 2023 | Year | 12 | Month | 18 | Day |
| 2024 | Year | 01 | Month | 01 | Day |
| 2024 | Year | 12 | Month | 31 | Day |
(Explanation of research content)
After the gastric X-ray examination is completed, the researcher will explain about participating in the questionnaire survey in the examination room.
(Observation of subjective symptoms and answering questionnaires)
Research subjects were observed after returning home, and the subjects were checked for "5.5.4 Observation and Test Items" such as their physical condition before the test, the number of times they took laxatives after the test, the number of days until barium stool was excreted, and their subjective symptoms up to one week later. After answering the questionnaire regarding the contents, mail it to the research office using a return envelope.
| 2024 | Year | 06 | Month | 06 | Day |
| 2024 | Year | 06 | Month | 06 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062381